The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi)
- PMID: 16033653
- PMCID: PMC1193983
- DOI: 10.1186/1475-2875-4-33
The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi)
Abstract
Intermittent preventive treatment (IPT) administers a full therapeutic course of an anti-malarial drug at predetermined intervals, regardless of infection or disease status. It is recommended by the World Health Organization (WHO) for protecting pregnant women from the adverse effects of malaria (IPTp) and shows great potential as a strategy for reducing illness from malaria during infancy (IPTi). Administered concurrently with standard immunizations, IPTi is expected to reduce the frequency of clinical disease, but to allow blood-stage infections to occur between treatments, thus allowing parasite-specific immunity to develop. While wide deployment of IPTi is being considered, it is important to assess other potential effects. Transmission conditions, drug choice and administration schedule will likely affect the possibility of post-treatment rebound in child morbidity and mortality and the increased spread of parasite drug resistance and should be considered when implementing IPTi.
Figures





Similar articles
-
Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria.PLoS Med. 2006 May;3(5):e141. doi: 10.1371/journal.pmed.0030141. Epub 2006 Apr 4. PLoS Med. 2006. PMID: 16573365 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Review of intermittent preventive treatment for malaria in infants and children.J Paediatr Child Health. 2007 Jun;43(6):424-8. doi: 10.1111/j.1440-1754.2007.01105.x. J Paediatr Child Health. 2007. PMID: 17535170 Review.
-
The effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement.Malar J. 2014 Nov 15;13:428. doi: 10.1186/1475-2875-13-428. Malar J. 2014. PMID: 25398463 Free PMC article.
-
Intermittent preventive treatment for malaria in infants.Cochrane Database Syst Rev. 2021 Jul 17;7(7):CD011525. doi: 10.1002/14651858.CD011525.pub3. Cochrane Database Syst Rev. 2021. PMID: 34273901 Free PMC article.
Cited by
-
Varying efficacy of intermittent preventive treatment for malaria in infants in two similar trials: public health implications.Malar J. 2007 Sep 26;6:132. doi: 10.1186/1475-2875-6-132. Malar J. 2007. PMID: 17897454 Free PMC article.
-
Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance.Malar J. 2007 Jan 22;6:9. doi: 10.1186/1475-2875-6-9. Malar J. 2007. PMID: 17241476 Free PMC article.
-
Intermittent preventive treatment in infants as a means of malaria control: a randomized, double-blind, placebo-controlled trial in northern Ghana.Antimicrob Agents Chemother. 2007 Sep;51(9):3273-81. doi: 10.1128/AAC.00513-07. Epub 2007 Jul 16. Antimicrob Agents Chemother. 2007. PMID: 17638703 Free PMC article. Clinical Trial.
-
Perception of Malaria Chemoprevention Interventions in Infants and Children in Eight Sub-Saharan African Countries: An End User Perspective Study.Trop Med Infect Dis. 2021 May 11;6(2):75. doi: 10.3390/tropicalmed6020075. Trop Med Infect Dis. 2021. PMID: 34064620 Free PMC article.
-
Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.Ther Clin Risk Manag. 2008 Aug;4(4):803-19. doi: 10.2147/tcrm.s1025. Ther Clin Risk Manag. 2008. PMID: 19209263 Free PMC article.
References
-
- Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, Broadhead RL. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol. 1998;92:141–150. doi: 10.1080/00034989859979. - DOI - PubMed
-
- Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW. Efficacy of sulfadoxlne-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg. 1998;59:813–822. - PubMed
-
- van Eijk AM, Ayisi JG, ter Kuile FO, Otieno JA, Misore AO, Odondi JO, Rosen DH, Kager PA, Steketee RW, Nahlen BL. Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Trop Med Int Health. 2004;9:351–360. doi: 10.1111/j.1365-3156.2004.01196.x. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical